Drug Eluting Balloons (DEB) Industry Research Report 2023
A drug-eluting balloon is a non-stent technology in which the effective homogenous delivery of anti-proliferative drugs is processed by the vessel wall through an inflated balloon. This is done to restore luminal vascularity in order to treat atherosclerosis, in-stent restenosis and reduce the risk of late thrombosis without implanting a permanent foreign object. The balloon technology relies on the concept of targeted drug delivery, which helps in the rapid healing of the vessel wall and prevents the proliferation of smooth muscle cells.
Drug eluting balloon is a semi-compliant angioplasty balloon, coated with anti-proliferative medicine. The medicine is ejected to the vessel walls during the inflation of the balloon. The balloons are inflated through application of nominal pressure.
Highlights
The global Drug Eluting Balloons (DEB) market is projected to reach US$ million by 2029 from an estimated US$ million in 2023, at a CAGR of % during 2024 and 2029.
Global Drug Eluting Balloons?DEB? key players include B. Braun, Medtronic, Boston Scientific, BD, Yinyi, etc. Global top 5 manufacturers hold a share over 84%.
Europe is the largest market, with a share about 42%, followed by North America, and Asia-Pacific, both have a share about 52 percent.
In terms of product, Peripheral DEBs is the largest segment, with a share over 57%. And in terms of application, the largest application is Hospital, followed by Catheterization Laboratory, Others.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Drug Eluting Balloons (DEB), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Drug Eluting Balloons (DEB).
The Drug Eluting Balloons (DEB) market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Drug Eluting Balloons (DEB) market comprehensively. Regional market sizes, concerning products by types, by application, and by players, are also provided. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Drug Eluting Balloons (DEB) manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2018-2023. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
Global markets are presented by Drug Eluting Balloons (DEB) type, along with growth forecasts through 2029. Estimates on sales and revenue are based on the price in the supply chain at which the Drug Eluting Balloons (DEB) are procured by the manufacturers.
This report has studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows sales and revenue data by type, and during the historical period (2018-2023) and forecast period (2024-2029).
Drug Eluting Balloons (DEB) segment by Type
This report has provided the market size (sales and revenue data) by application, during the historical period (2018-2023) and forecast period (2024-2029).
This report also outlines the market trends of each segment and consumer behaviors impacting the Drug Eluting Balloons (DEB) market and what implications these may have on the industry's future. This report can help to understand the relevant market and consumer trends that are driving the Drug Eluting Balloons (DEB) market.
Drug Eluting Balloons (DEB) segment by Application
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue and sales data of each region and country for the period 2018-2029.
The market has been segmented into various major geographies, including North America, Europe, Asia-Pacific, South America, Middle East & Africa. Detailed analysis of major countries such as the USA, Germany, the U.K., Italy, France, China, Japan, South Korea, Southeast Asia, and India will be covered within the regional segment. For market estimates, data are going to be provided for 2021 because of the base year, with estimates for 2023 and forecast revenue for 2029.
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Drug Eluting Balloons (DEB) market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Reasons to Buy This Report
This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Drug Eluting Balloons (DEB) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
This report will help stakeholders to understand the global industry status and trends of Drug Eluting Balloons (DEB) and provides them with information on key market drivers, restraints, challenges, and opportunities.
This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
This report stays updated with novel technology integration, features, and the latest developments in the market
This report helps stakeholders to understand the COVID-19 and Russia-Ukraine War Influence on the Drug Eluting Balloons (DEB) industry.
This report helps stakeholders to gain insights into which regions to target globally
This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Drug Eluting Balloons (DEB).
This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Core Chapters
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Drug Eluting Balloons (DEB) manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Drug Eluting Balloons (DEB) by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Drug Eluting Balloons (DEB) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
Frequently Asked Questions
Drug eluting balloon is a semi-compliant angioplasty balloon, coated with anti-proliferative medicine. The medicine is ejected to the vessel walls during the inflation of the balloon. The balloons are inflated through application of nominal pressure.
Highlights
The global Drug Eluting Balloons (DEB) market is projected to reach US$ million by 2029 from an estimated US$ million in 2023, at a CAGR of % during 2024 and 2029.
Global Drug Eluting Balloons?DEB? key players include B. Braun, Medtronic, Boston Scientific, BD, Yinyi, etc. Global top 5 manufacturers hold a share over 84%.
Europe is the largest market, with a share about 42%, followed by North America, and Asia-Pacific, both have a share about 52 percent.
In terms of product, Peripheral DEBs is the largest segment, with a share over 57%. And in terms of application, the largest application is Hospital, followed by Catheterization Laboratory, Others.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Drug Eluting Balloons (DEB), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Drug Eluting Balloons (DEB).
The Drug Eluting Balloons (DEB) market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Drug Eluting Balloons (DEB) market comprehensively. Regional market sizes, concerning products by types, by application, and by players, are also provided. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Drug Eluting Balloons (DEB) manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2018-2023. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
- B. Braun
- Medtronic
- Boston Scientific
- BD
- Yinyi
- Philips
- Eurocor
- Aachen Resonance
- Biotronic
Global markets are presented by Drug Eluting Balloons (DEB) type, along with growth forecasts through 2029. Estimates on sales and revenue are based on the price in the supply chain at which the Drug Eluting Balloons (DEB) are procured by the manufacturers.
This report has studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows sales and revenue data by type, and during the historical period (2018-2023) and forecast period (2024-2029).
Drug Eluting Balloons (DEB) segment by Type
- Peripheral DEBs
- Coronary DEBs
This report has provided the market size (sales and revenue data) by application, during the historical period (2018-2023) and forecast period (2024-2029).
This report also outlines the market trends of each segment and consumer behaviors impacting the Drug Eluting Balloons (DEB) market and what implications these may have on the industry's future. This report can help to understand the relevant market and consumer trends that are driving the Drug Eluting Balloons (DEB) market.
Drug Eluting Balloons (DEB) segment by Application
- Catheterization Laboratory
- Hospital
- Others
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue and sales data of each region and country for the period 2018-2029.
The market has been segmented into various major geographies, including North America, Europe, Asia-Pacific, South America, Middle East & Africa. Detailed analysis of major countries such as the USA, Germany, the U.K., Italy, France, China, Japan, South Korea, Southeast Asia, and India will be covered within the regional segment. For market estimates, data are going to be provided for 2021 because of the base year, with estimates for 2023 and forecast revenue for 2029.
- North America
- United States
- Canada
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Australia
- China Taiwan
- Indonesia
- Thailand
- Malaysia
- Latin America
- Mexico
- Brazil
- Argentina
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Drug Eluting Balloons (DEB) market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Reasons to Buy This Report
This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Drug Eluting Balloons (DEB) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
This report will help stakeholders to understand the global industry status and trends of Drug Eluting Balloons (DEB) and provides them with information on key market drivers, restraints, challenges, and opportunities.
This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
This report stays updated with novel technology integration, features, and the latest developments in the market
This report helps stakeholders to understand the COVID-19 and Russia-Ukraine War Influence on the Drug Eluting Balloons (DEB) industry.
This report helps stakeholders to gain insights into which regions to target globally
This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Drug Eluting Balloons (DEB).
This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Core Chapters
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Drug Eluting Balloons (DEB) manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Drug Eluting Balloons (DEB) by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Drug Eluting Balloons (DEB) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
Frequently Asked Questions
- Which product segment grabbed the largest share in the Product Name market?
- How is the competitive scenario of the Product Name market?
- Which are the key factors aiding the Product Name market growth?
- Which are the prominent players in the Product Name market?
- Which region holds the maximum share in the Product Name market?
- What will be the CAGR of the Product Name market during the forecast period?
- Which application segment emerged as the leading segment in the Product Name market?
- What key trends are likely to emerge in the Product Name market in the coming years?
- What will be the Product Name market size by 2028?
- Which company held the largest share in the Product Name market?
LIST OF TABLES
Table 1. Secondary Sources
Table 2. Primary Sources
Table 3. Market Value Comparison by Type (2018 VS 2022 VS 2029) & (US$ Million)
Table 4. Market Value Comparison by Application (2018 VS 2022 VS 2029) & (US$ Million)
Table 5. Global Drug Eluting Balloons (DEB) Volume and Revenue Market Size and CAGR of Manufacturers (2018 Versus 2022)
Table 6. Global Drug Eluting Balloons (DEB) Sales (K Units) of Manufacturers (2018-2023)
Table 7. Global Drug Eluting Balloons (DEB) Sales Market Share by Manufacturers (2018-2023)
Table 8. Global Drug Eluting Balloons (DEB) Revenue of Manufacturers (2018-2023)
Table 9. Global Drug Eluting Balloons (DEB) Revenue Share by Manufacturers (2018-2023)
Table 10. Global Market Drug Eluting Balloons (DEB) Average Price (US$/Unit) of Manufacturers (2018-2023)
Table 11. Global Drug Eluting Balloons (DEB) Industry Ranking, 2021 VS 2022 VS 2023
Table 12. Global Manufacturers of Drug Eluting Balloons (DEB), Product Type & Application
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Drug Eluting Balloons (DEB) by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans)
Table 16. B. Braun Company Information
Table 17. B. Braun Business Overview
Table 18. B. Braun Drug Eluting Balloons (DEB) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 19. B. Braun Drug Eluting Balloons (DEB) Product Portfolio
Table 20. B. Braun Recent Developments
Table 21. Medtronic Company Information
Table 22. Medtronic Business Overview
Table 23. Medtronic Drug Eluting Balloons (DEB) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 24. Medtronic Drug Eluting Balloons (DEB) Product Portfolio
Table 25. Medtronic Recent Developments
Table 26. Boston Scientific Company Information
Table 27. Boston Scientific Business Overview
Table 28. Boston Scientific Drug Eluting Balloons (DEB) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 29. Boston Scientific Drug Eluting Balloons (DEB) Product Portfolio
Table 30. Boston Scientific Recent Developments
Table 31. BD Company Information
Table 32. BD Business Overview
Table 33. BD Drug Eluting Balloons (DEB) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 34. BD Drug Eluting Balloons (DEB) Product Portfolio
Table 35. BD Recent Developments
Table 36. Yinyi Company Information
Table 37. Yinyi Business Overview
Table 38. Yinyi Drug Eluting Balloons (DEB) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 39. Yinyi Drug Eluting Balloons (DEB) Product Portfolio
Table 40. Yinyi Recent Developments
Table 41. Philips Company Information
Table 42. Philips Business Overview
Table 43. Philips Drug Eluting Balloons (DEB) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 44. Philips Drug Eluting Balloons (DEB) Product Portfolio
Table 45. Philips Recent Developments
Table 46. Eurocor Company Information
Table 47. Eurocor Business Overview
Table 48. Eurocor Drug Eluting Balloons (DEB) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 49. Eurocor Drug Eluting Balloons (DEB) Product Portfolio
Table 50. Eurocor Recent Developments
Table 51. Aachen Resonance Company Information
Table 52. Aachen Resonance Business Overview
Table 53. Aachen Resonance Drug Eluting Balloons (DEB) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 54. Aachen Resonance Drug Eluting Balloons (DEB) Product Portfolio
Table 55. Aachen Resonance Recent Developments
Table 56. Biotronic Company Information
Table 57. Biotronic Business Overview
Table 58. Biotronic Drug Eluting Balloons (DEB) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 59. Biotronic Drug Eluting Balloons (DEB) Product Portfolio
Table 60. Biotronic Recent Developments
Table 61. Global Drug Eluting Balloons (DEB) Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 62. Global Drug Eluting Balloons (DEB) Sales by Region (2018-2023) & (K Units)
Table 63. Global Drug Eluting Balloons (DEB) Sales Market Share by Region (2018-2023)
Table 64. Global Drug Eluting Balloons (DEB) Sales by Region (2024-2029) & (K Units)
Table 65. Global Drug Eluting Balloons (DEB) Sales Market Share by Region (2024-2029)
Table 66. Global Drug Eluting Balloons (DEB) Revenue by Region (2018-2023) & (US$ Million)
Table 67. Global Drug Eluting Balloons (DEB) Revenue Market Share by Region (2018-2023)
Table 68. Global Drug Eluting Balloons (DEB) Revenue by Region (2024-2029) & (US$ Million)
Table 69. Global Drug Eluting Balloons (DEB) Revenue Market Share by Region (2024-2029)
Table 70. North America Drug Eluting Balloons (DEB) Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 71. North America Drug Eluting Balloons (DEB) Sales by Country (2018-2023) & (K Units)
Table 72. North America Drug Eluting Balloons (DEB) Sales by Country (2024-2029) & (K Units)
Table 73. North America Drug Eluting Balloons (DEB) Revenue by Country (2018-2023) & (US$ Million)
Table 74. North America Drug Eluting Balloons (DEB) Revenue by Country (2024-2029) & (US$ Million)
Table 75. Europe Drug Eluting Balloons (DEB) Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 76. Europe Drug Eluting Balloons (DEB) Sales by Country (2018-2023) & (K Units)
Table 77. Europe Drug Eluting Balloons (DEB) Sales by Country (2024-2029) & (K Units)
Table 78. Europe Drug Eluting Balloons (DEB) Revenue by Country (2018-2023) & (US$ Million)
Table 79. Europe Drug Eluting Balloons (DEB) Revenue by Country (2024-2029) & (US$ Million)
Table 80. Asia Pacific Drug Eluting Balloons (DEB) Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 81. Asia Pacific Drug Eluting Balloons (DEB) Sales by Country (2018-2023) & (K Units)
Table 82. Asia Pacific Drug Eluting Balloons (DEB) Sales by Country (2024-2029) & (K Units)
Table 83. Asia Pacific Drug Eluting Balloons (DEB) Revenue by Country (2018-2023) & (US$ Million)
Table 84. Asia Pacific Drug Eluting Balloons (DEB) Revenue by Country (2024-2029) & (US$ Million)
Table 85. Latin America Drug Eluting Balloons (DEB) Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 86. Latin America Drug Eluting Balloons (DEB) Sales by Country (2018-2023) & (K Units)
Table 87. Latin America Drug Eluting Balloons (DEB) Sales by Country (2024-2029) & (K Units)
Table 88. Latin America Drug Eluting Balloons (DEB) Revenue by Country (2018-2023) & (US$ Million)
Table 89. Latin America Drug Eluting Balloons (DEB) Revenue by Country (2024-2029) & (US$ Million)
Table 90. Middle East and Africa Drug Eluting Balloons (DEB) Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 91. Middle East and Africa Drug Eluting Balloons (DEB) Sales by Country (2018-2023) & (K Units)
Table 92. Middle East and Africa Drug Eluting Balloons (DEB) Sales by Country (2024-2029) & (K Units)
Table 93. Middle East and Africa Drug Eluting Balloons (DEB) Revenue by Country (2018-2023) & (US$ Million)
Table 94. Middle East and Africa Drug Eluting Balloons (DEB) Revenue by Country (2024-2029) & (US$ Million)
Table 95. Global Drug Eluting Balloons (DEB) Sales by Type (2018-2023) & (K Units)
Table 96. Global Drug Eluting Balloons (DEB) Sales by Type (2024-2029) & (K Units)
Table 97. Global Drug Eluting Balloons (DEB) Sales Market Share by Type (2018-2023)
Table 98. Global Drug Eluting Balloons (DEB) Sales Market Share by Type (2024-2029)
Table 99. Global Drug Eluting Balloons (DEB) Revenue by Type (2018-2023) & (US$ Million)
Table 100. Global Drug Eluting Balloons (DEB) Revenue by Type (2024-2029) & (US$ Million)
Table 101. Global Drug Eluting Balloons (DEB) Revenue Market Share by Type (2018-2023)
Table 102. Global Drug Eluting Balloons (DEB) Revenue Market Share by Type (2024-2029)
Table 103. Global Drug Eluting Balloons (DEB) Price by Type (2018-2023) & (US$/Unit)
Table 104. Global Drug Eluting Balloons (DEB) Price by Type (2024-2029) & (US$/Unit)
Table 105. Global Drug Eluting Balloons (DEB) Sales by Application (2018-2023) & (K Units)
Table 106. Global Drug Eluting Balloons (DEB) Sales by Application (2024-2029) & (K Units)
Table 107. Global Drug Eluting Balloons (DEB) Sales Market Share by Application (2018-2023)
Table 108. Global Drug Eluting Balloons (DEB) Sales Market Share by Application (2024-2029)
Table 109. Global Drug Eluting Balloons (DEB) Revenue by Application (2018-2023) & (US$ Million)
Table 110. Global Drug Eluting Balloons (DEB) Revenue by Application (2024-2029) & (US$ Million)
Table 111. Global Drug Eluting Balloons (DEB) Revenue Market Share by Application (2018-2023)
Table 112. Global Drug Eluting Balloons (DEB) Revenue Market Share by Application (2024-2029)
Table 113. Global Drug Eluting Balloons (DEB) Price by Application (2018-2023) & (US$/Unit)
Table 114. Global Drug Eluting Balloons (DEB) Price by Application (2024-2029) & (US$/Unit)
Table 115. Key Raw Materials
Table 116. Raw Materials Key Suppliers
Table 117. Drug Eluting Balloons (DEB) Distributors List
Table 118. Drug Eluting Balloons (DEB) Customers List
Table 119. Drug Eluting Balloons (DEB) Industry Trends
Table 120. Drug Eluting Balloons (DEB) Industry Drivers
Table 121. Drug Eluting Balloons (DEB) Industry Restraints
Table 122. Authors 12. List of This Report
Table 1. Secondary Sources
Table 2. Primary Sources
Table 3. Market Value Comparison by Type (2018 VS 2022 VS 2029) & (US$ Million)
Table 4. Market Value Comparison by Application (2018 VS 2022 VS 2029) & (US$ Million)
Table 5. Global Drug Eluting Balloons (DEB) Volume and Revenue Market Size and CAGR of Manufacturers (2018 Versus 2022)
Table 6. Global Drug Eluting Balloons (DEB) Sales (K Units) of Manufacturers (2018-2023)
Table 7. Global Drug Eluting Balloons (DEB) Sales Market Share by Manufacturers (2018-2023)
Table 8. Global Drug Eluting Balloons (DEB) Revenue of Manufacturers (2018-2023)
Table 9. Global Drug Eluting Balloons (DEB) Revenue Share by Manufacturers (2018-2023)
Table 10. Global Market Drug Eluting Balloons (DEB) Average Price (US$/Unit) of Manufacturers (2018-2023)
Table 11. Global Drug Eluting Balloons (DEB) Industry Ranking, 2021 VS 2022 VS 2023
Table 12. Global Manufacturers of Drug Eluting Balloons (DEB), Product Type & Application
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Drug Eluting Balloons (DEB) by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans)
Table 16. B. Braun Company Information
Table 17. B. Braun Business Overview
Table 18. B. Braun Drug Eluting Balloons (DEB) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 19. B. Braun Drug Eluting Balloons (DEB) Product Portfolio
Table 20. B. Braun Recent Developments
Table 21. Medtronic Company Information
Table 22. Medtronic Business Overview
Table 23. Medtronic Drug Eluting Balloons (DEB) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 24. Medtronic Drug Eluting Balloons (DEB) Product Portfolio
Table 25. Medtronic Recent Developments
Table 26. Boston Scientific Company Information
Table 27. Boston Scientific Business Overview
Table 28. Boston Scientific Drug Eluting Balloons (DEB) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 29. Boston Scientific Drug Eluting Balloons (DEB) Product Portfolio
Table 30. Boston Scientific Recent Developments
Table 31. BD Company Information
Table 32. BD Business Overview
Table 33. BD Drug Eluting Balloons (DEB) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 34. BD Drug Eluting Balloons (DEB) Product Portfolio
Table 35. BD Recent Developments
Table 36. Yinyi Company Information
Table 37. Yinyi Business Overview
Table 38. Yinyi Drug Eluting Balloons (DEB) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 39. Yinyi Drug Eluting Balloons (DEB) Product Portfolio
Table 40. Yinyi Recent Developments
Table 41. Philips Company Information
Table 42. Philips Business Overview
Table 43. Philips Drug Eluting Balloons (DEB) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 44. Philips Drug Eluting Balloons (DEB) Product Portfolio
Table 45. Philips Recent Developments
Table 46. Eurocor Company Information
Table 47. Eurocor Business Overview
Table 48. Eurocor Drug Eluting Balloons (DEB) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 49. Eurocor Drug Eluting Balloons (DEB) Product Portfolio
Table 50. Eurocor Recent Developments
Table 51. Aachen Resonance Company Information
Table 52. Aachen Resonance Business Overview
Table 53. Aachen Resonance Drug Eluting Balloons (DEB) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 54. Aachen Resonance Drug Eluting Balloons (DEB) Product Portfolio
Table 55. Aachen Resonance Recent Developments
Table 56. Biotronic Company Information
Table 57. Biotronic Business Overview
Table 58. Biotronic Drug Eluting Balloons (DEB) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 59. Biotronic Drug Eluting Balloons (DEB) Product Portfolio
Table 60. Biotronic Recent Developments
Table 61. Global Drug Eluting Balloons (DEB) Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 62. Global Drug Eluting Balloons (DEB) Sales by Region (2018-2023) & (K Units)
Table 63. Global Drug Eluting Balloons (DEB) Sales Market Share by Region (2018-2023)
Table 64. Global Drug Eluting Balloons (DEB) Sales by Region (2024-2029) & (K Units)
Table 65. Global Drug Eluting Balloons (DEB) Sales Market Share by Region (2024-2029)
Table 66. Global Drug Eluting Balloons (DEB) Revenue by Region (2018-2023) & (US$ Million)
Table 67. Global Drug Eluting Balloons (DEB) Revenue Market Share by Region (2018-2023)
Table 68. Global Drug Eluting Balloons (DEB) Revenue by Region (2024-2029) & (US$ Million)
Table 69. Global Drug Eluting Balloons (DEB) Revenue Market Share by Region (2024-2029)
Table 70. North America Drug Eluting Balloons (DEB) Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 71. North America Drug Eluting Balloons (DEB) Sales by Country (2018-2023) & (K Units)
Table 72. North America Drug Eluting Balloons (DEB) Sales by Country (2024-2029) & (K Units)
Table 73. North America Drug Eluting Balloons (DEB) Revenue by Country (2018-2023) & (US$ Million)
Table 74. North America Drug Eluting Balloons (DEB) Revenue by Country (2024-2029) & (US$ Million)
Table 75. Europe Drug Eluting Balloons (DEB) Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 76. Europe Drug Eluting Balloons (DEB) Sales by Country (2018-2023) & (K Units)
Table 77. Europe Drug Eluting Balloons (DEB) Sales by Country (2024-2029) & (K Units)
Table 78. Europe Drug Eluting Balloons (DEB) Revenue by Country (2018-2023) & (US$ Million)
Table 79. Europe Drug Eluting Balloons (DEB) Revenue by Country (2024-2029) & (US$ Million)
Table 80. Asia Pacific Drug Eluting Balloons (DEB) Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 81. Asia Pacific Drug Eluting Balloons (DEB) Sales by Country (2018-2023) & (K Units)
Table 82. Asia Pacific Drug Eluting Balloons (DEB) Sales by Country (2024-2029) & (K Units)
Table 83. Asia Pacific Drug Eluting Balloons (DEB) Revenue by Country (2018-2023) & (US$ Million)
Table 84. Asia Pacific Drug Eluting Balloons (DEB) Revenue by Country (2024-2029) & (US$ Million)
Table 85. Latin America Drug Eluting Balloons (DEB) Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 86. Latin America Drug Eluting Balloons (DEB) Sales by Country (2018-2023) & (K Units)
Table 87. Latin America Drug Eluting Balloons (DEB) Sales by Country (2024-2029) & (K Units)
Table 88. Latin America Drug Eluting Balloons (DEB) Revenue by Country (2018-2023) & (US$ Million)
Table 89. Latin America Drug Eluting Balloons (DEB) Revenue by Country (2024-2029) & (US$ Million)
Table 90. Middle East and Africa Drug Eluting Balloons (DEB) Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 91. Middle East and Africa Drug Eluting Balloons (DEB) Sales by Country (2018-2023) & (K Units)
Table 92. Middle East and Africa Drug Eluting Balloons (DEB) Sales by Country (2024-2029) & (K Units)
Table 93. Middle East and Africa Drug Eluting Balloons (DEB) Revenue by Country (2018-2023) & (US$ Million)
Table 94. Middle East and Africa Drug Eluting Balloons (DEB) Revenue by Country (2024-2029) & (US$ Million)
Table 95. Global Drug Eluting Balloons (DEB) Sales by Type (2018-2023) & (K Units)
Table 96. Global Drug Eluting Balloons (DEB) Sales by Type (2024-2029) & (K Units)
Table 97. Global Drug Eluting Balloons (DEB) Sales Market Share by Type (2018-2023)
Table 98. Global Drug Eluting Balloons (DEB) Sales Market Share by Type (2024-2029)
Table 99. Global Drug Eluting Balloons (DEB) Revenue by Type (2018-2023) & (US$ Million)
Table 100. Global Drug Eluting Balloons (DEB) Revenue by Type (2024-2029) & (US$ Million)
Table 101. Global Drug Eluting Balloons (DEB) Revenue Market Share by Type (2018-2023)
Table 102. Global Drug Eluting Balloons (DEB) Revenue Market Share by Type (2024-2029)
Table 103. Global Drug Eluting Balloons (DEB) Price by Type (2018-2023) & (US$/Unit)
Table 104. Global Drug Eluting Balloons (DEB) Price by Type (2024-2029) & (US$/Unit)
Table 105. Global Drug Eluting Balloons (DEB) Sales by Application (2018-2023) & (K Units)
Table 106. Global Drug Eluting Balloons (DEB) Sales by Application (2024-2029) & (K Units)
Table 107. Global Drug Eluting Balloons (DEB) Sales Market Share by Application (2018-2023)
Table 108. Global Drug Eluting Balloons (DEB) Sales Market Share by Application (2024-2029)
Table 109. Global Drug Eluting Balloons (DEB) Revenue by Application (2018-2023) & (US$ Million)
Table 110. Global Drug Eluting Balloons (DEB) Revenue by Application (2024-2029) & (US$ Million)
Table 111. Global Drug Eluting Balloons (DEB) Revenue Market Share by Application (2018-2023)
Table 112. Global Drug Eluting Balloons (DEB) Revenue Market Share by Application (2024-2029)
Table 113. Global Drug Eluting Balloons (DEB) Price by Application (2018-2023) & (US$/Unit)
Table 114. Global Drug Eluting Balloons (DEB) Price by Application (2024-2029) & (US$/Unit)
Table 115. Key Raw Materials
Table 116. Raw Materials Key Suppliers
Table 117. Drug Eluting Balloons (DEB) Distributors List
Table 118. Drug Eluting Balloons (DEB) Customers List
Table 119. Drug Eluting Balloons (DEB) Industry Trends
Table 120. Drug Eluting Balloons (DEB) Industry Drivers
Table 121. Drug Eluting Balloons (DEB) Industry Restraints
Table 122. Authors 12. List of This Report
LIST OF FIGURES
Figure 1. Research Methodology
Figure 2. Research Process
Figure 3. Key Executives Interviewed
Figure 4. Drug Eluting Balloons (DEB)Product Picture
Figure 5. Global Drug Eluting Balloons (DEB) Revenue (US$ Million), 2018 VS 2022 VS 2029
Figure 6. Global Drug Eluting Balloons (DEB) Market Size (2018-2029) & (US$ Million)
Figure 7. Global Drug Eluting Balloons (DEB) Sales (2018-2029) & (K Units)
Figure 8. Global Drug Eluting Balloons (DEB) Average Price (US$/Unit) & (2018-2029)
Figure 9. Peripheral DEBs Product Picture
Figure 10. Coronary DEBs Product Picture
Figure 11. Catheterization Laboratory Product Picture
Figure 12. Hospital Product Picture
Figure 13. Others Product Picture
Figure 14. Global Drug Eluting Balloons (DEB) Revenue Share by Manufacturers in 2022
Figure 15. Global Manufacturers of Drug Eluting Balloons (DEB), Manufacturing Sites & Headquarters
Figure 16. Global Manufacturers of Drug Eluting Balloons (DEB), Date of Enter into This Industry
Figure 17. Global Top 5 and 10 Drug Eluting Balloons (DEB) Players Market Share by Revenue in 2022
Figure 18. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 19. Global Drug Eluting Balloons (DEB) Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 20. Global Drug Eluting Balloons (DEB) Sales by Region in 2022
Figure 21. Global Drug Eluting Balloons (DEB) Revenue by Region in 2022
Figure 22. North America Drug Eluting Balloons (DEB) Market Size by Country in 2022
Figure 23. North America Drug Eluting Balloons (DEB) Sales Market Share by Country (2018-2029)
Figure 24. North America Drug Eluting Balloons (DEB) Revenue Market Share by Country (2018-2029)
Figure 25. United States Drug Eluting Balloons (DEB) Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 26. Canada Drug Eluting Balloons (DEB) Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 27. Europe Drug Eluting Balloons (DEB) Market Size by Country in 2022
Figure 28. Europe Drug Eluting Balloons (DEB) Sales Market Share by Country (2018-2029)
Figure 29. Europe Drug Eluting Balloons (DEB) Revenue Market Share by Country (2018-2029)
Figure 30. Germany Drug Eluting Balloons (DEB) Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 31. France Drug Eluting Balloons (DEB) Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 32. U.K. Drug Eluting Balloons (DEB) Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 33. Italy Drug Eluting Balloons (DEB) Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 34. Russia Drug Eluting Balloons (DEB) Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 35. Asia Pacific Drug Eluting Balloons (DEB) Market Size by Country in 2022
Figure 36. Asia Pacific Drug Eluting Balloons (DEB) Sales Market Share by Country (2018-2029)
Figure 37. Asia Pacific Drug Eluting Balloons (DEB) Revenue Market Share by Country (2018-2029)
Figure 38. China Drug Eluting Balloons (DEB) Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. Japan Drug Eluting Balloons (DEB) Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. South Korea Drug Eluting Balloons (DEB) Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. India Drug Eluting Balloons (DEB) Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 42. Australia Drug Eluting Balloons (DEB) Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 43. China Taiwan Drug Eluting Balloons (DEB) Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 44. Indonesia Drug Eluting Balloons (DEB) Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 45. Thailand Drug Eluting Balloons (DEB) Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 46. Malaysia Drug Eluting Balloons (DEB) Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 47. Latin America Drug Eluting Balloons (DEB) Market Size by Country in 2022
Figure 48. Latin America Drug Eluting Balloons (DEB) Sales Market Share by Country (2018-2029)
Figure 49. Latin America Drug Eluting Balloons (DEB) Revenue Market Share by Country (2018-2029)
Figure 50. Mexico Drug Eluting Balloons (DEB) Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 51. Brazil Drug Eluting Balloons (DEB) Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 52. Argentina Drug Eluting Balloons (DEB) Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 53. Middle East and Africa Drug Eluting Balloons (DEB) Market Size by Country in 2022
Figure 54. Middle East and Africa Drug Eluting Balloons (DEB) Sales Market Share by Country (2018-2029)
Figure 55. Middle East and Africa Drug Eluting Balloons (DEB) Revenue Market Share by Country (2018-2029)
Figure 56. Turkey Drug Eluting Balloons (DEB) Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 57. Saudi Arabia Drug Eluting Balloons (DEB) Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 58. UAE Drug Eluting Balloons (DEB) Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 59. Global Drug Eluting Balloons (DEB) Sales Market Share by Type (2018-2029)
Figure 60. Global Drug Eluting Balloons (DEB) Revenue Market Share by Type (2018-2029)
Figure 61. Global Drug Eluting Balloons (DEB) Price (US$/Unit) by Type (2018-2029)
Figure 62. Global Drug Eluting Balloons (DEB) Sales Market Share by Application (2018-2029)
Figure 63. Global Drug Eluting Balloons (DEB) Revenue Market Share by Application (2018-2029)
Figure 64. Global Drug Eluting Balloons (DEB) Price (US$/Unit) by Application (2018-2029)
Figure 65. Drug Eluting Balloons (DEB) Value Chain
Figure 66. Drug Eluting Balloons (DEB) Production Mode & Process
Figure 67. Direct Comparison with Distribution Share
Figure 68. Distributors Profiles
Figure 69. Drug Eluting Balloons (DEB) Industry Opportunities and Challenges
Figure 1. Research Methodology
Figure 2. Research Process
Figure 3. Key Executives Interviewed
Figure 4. Drug Eluting Balloons (DEB)Product Picture
Figure 5. Global Drug Eluting Balloons (DEB) Revenue (US$ Million), 2018 VS 2022 VS 2029
Figure 6. Global Drug Eluting Balloons (DEB) Market Size (2018-2029) & (US$ Million)
Figure 7. Global Drug Eluting Balloons (DEB) Sales (2018-2029) & (K Units)
Figure 8. Global Drug Eluting Balloons (DEB) Average Price (US$/Unit) & (2018-2029)
Figure 9. Peripheral DEBs Product Picture
Figure 10. Coronary DEBs Product Picture
Figure 11. Catheterization Laboratory Product Picture
Figure 12. Hospital Product Picture
Figure 13. Others Product Picture
Figure 14. Global Drug Eluting Balloons (DEB) Revenue Share by Manufacturers in 2022
Figure 15. Global Manufacturers of Drug Eluting Balloons (DEB), Manufacturing Sites & Headquarters
Figure 16. Global Manufacturers of Drug Eluting Balloons (DEB), Date of Enter into This Industry
Figure 17. Global Top 5 and 10 Drug Eluting Balloons (DEB) Players Market Share by Revenue in 2022
Figure 18. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 19. Global Drug Eluting Balloons (DEB) Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 20. Global Drug Eluting Balloons (DEB) Sales by Region in 2022
Figure 21. Global Drug Eluting Balloons (DEB) Revenue by Region in 2022
Figure 22. North America Drug Eluting Balloons (DEB) Market Size by Country in 2022
Figure 23. North America Drug Eluting Balloons (DEB) Sales Market Share by Country (2018-2029)
Figure 24. North America Drug Eluting Balloons (DEB) Revenue Market Share by Country (2018-2029)
Figure 25. United States Drug Eluting Balloons (DEB) Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 26. Canada Drug Eluting Balloons (DEB) Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 27. Europe Drug Eluting Balloons (DEB) Market Size by Country in 2022
Figure 28. Europe Drug Eluting Balloons (DEB) Sales Market Share by Country (2018-2029)
Figure 29. Europe Drug Eluting Balloons (DEB) Revenue Market Share by Country (2018-2029)
Figure 30. Germany Drug Eluting Balloons (DEB) Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 31. France Drug Eluting Balloons (DEB) Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 32. U.K. Drug Eluting Balloons (DEB) Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 33. Italy Drug Eluting Balloons (DEB) Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 34. Russia Drug Eluting Balloons (DEB) Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 35. Asia Pacific Drug Eluting Balloons (DEB) Market Size by Country in 2022
Figure 36. Asia Pacific Drug Eluting Balloons (DEB) Sales Market Share by Country (2018-2029)
Figure 37. Asia Pacific Drug Eluting Balloons (DEB) Revenue Market Share by Country (2018-2029)
Figure 38. China Drug Eluting Balloons (DEB) Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. Japan Drug Eluting Balloons (DEB) Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. South Korea Drug Eluting Balloons (DEB) Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. India Drug Eluting Balloons (DEB) Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 42. Australia Drug Eluting Balloons (DEB) Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 43. China Taiwan Drug Eluting Balloons (DEB) Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 44. Indonesia Drug Eluting Balloons (DEB) Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 45. Thailand Drug Eluting Balloons (DEB) Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 46. Malaysia Drug Eluting Balloons (DEB) Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 47. Latin America Drug Eluting Balloons (DEB) Market Size by Country in 2022
Figure 48. Latin America Drug Eluting Balloons (DEB) Sales Market Share by Country (2018-2029)
Figure 49. Latin America Drug Eluting Balloons (DEB) Revenue Market Share by Country (2018-2029)
Figure 50. Mexico Drug Eluting Balloons (DEB) Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 51. Brazil Drug Eluting Balloons (DEB) Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 52. Argentina Drug Eluting Balloons (DEB) Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 53. Middle East and Africa Drug Eluting Balloons (DEB) Market Size by Country in 2022
Figure 54. Middle East and Africa Drug Eluting Balloons (DEB) Sales Market Share by Country (2018-2029)
Figure 55. Middle East and Africa Drug Eluting Balloons (DEB) Revenue Market Share by Country (2018-2029)
Figure 56. Turkey Drug Eluting Balloons (DEB) Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 57. Saudi Arabia Drug Eluting Balloons (DEB) Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 58. UAE Drug Eluting Balloons (DEB) Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 59. Global Drug Eluting Balloons (DEB) Sales Market Share by Type (2018-2029)
Figure 60. Global Drug Eluting Balloons (DEB) Revenue Market Share by Type (2018-2029)
Figure 61. Global Drug Eluting Balloons (DEB) Price (US$/Unit) by Type (2018-2029)
Figure 62. Global Drug Eluting Balloons (DEB) Sales Market Share by Application (2018-2029)
Figure 63. Global Drug Eluting Balloons (DEB) Revenue Market Share by Application (2018-2029)
Figure 64. Global Drug Eluting Balloons (DEB) Price (US$/Unit) by Application (2018-2029)
Figure 65. Drug Eluting Balloons (DEB) Value Chain
Figure 66. Drug Eluting Balloons (DEB) Production Mode & Process
Figure 67. Direct Comparison with Distribution Share
Figure 68. Distributors Profiles
Figure 69. Drug Eluting Balloons (DEB) Industry Opportunities and Challenges
